- Tickets linked to stolen passports purchased by Iranian middleman
- More than 3,500 police planned for Boston Marathon
- Real-life Dr. Doolittle to reveal how to talk to animals
- Climate change could bring back smallpox, researchers say
- Shoe-bomb witness to speak from London at N.Y. trial
- New evidence could threaten Army sex assault case
- George Zimmerman signs autographs at Orlando gun show
- GOP lawmaker faces fire for NBA crime tweet
- Taliban vow to ‘use all force’ to disrupt Afghan elections
- Atheists sue to remove ‘Ground Zero Cross’ from 9/11 museum
Latest FDA Items
In his State of the Union address, President Obama tried to inspire confidence and urged a spirit of cooperation among members of the newly elected Congress. But what the president neglected to mention is the prominent role Planned Parenthood, the nation's largest abortion provider, is playing in shaping some of his administration's decisions.
Federal health officials said Wednesday they are investigating a possible link between breast implants and a very rare form of cancer, raising new questions about the safety of devices which have been scrutinized for decades.
The Food and Drug Administration is recommending stricter safety measures for heart-zapping defibrillators after years of increasing problems with the emergency medical devices.
The Food and Drug Administration is laying out plans to update the 35-year-old system used to approve most medical devices, which has been subject to increasing criticism by public safety advocates.
SMALL OVERHAUL: The Food and Drug Administration announced updates to how medical devices are approved, but backed away from broader changes opposed by industry.
What would happen if Roe v. Wade were overturned tomorrow? Regardless of how far in the future that day might be, states already are preparing for this eventuality.
LIVER RISK: The Food and Drug Administration is adding new warnings to the label of Sanofi-Aventis' drug Multaq after several reports of liver damage by patients taking the drug.
Federal health officials are warning doctors and patients that a recently-launched heart drug from Sanofi-Aventis SA has been linked to liver damage in a handful of patients.
Federal health regulators are limiting a key ingredient found in Vicodin, Percocet and other prescription painkillers that have been linked to thousands of cases of liver damage each year.